Fibrinogen Bonn (p. Arg510Cys) in the Aα-Chain Is Associated with High Risk of Venous Thrombosis
Hämostaseologie · 01.12.2023 · 43 (06) · 440-446
DOI: 10.1055/a-2094-7191 ↗Kurz gefasst
Fallbericht in der Zeitschrift Hämostaseologie, erschienen am 01.12.2023. Verfasst von V Ivaškevičius und 8 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Experimental Hematology and Transfusion Medicine, University Hospital Bonn, Bonn, Germany. Hauptthemen laut MEDLINE: Venous Thromboembolism, Afibrinogenemia, Venous Thrombosis, Thrombosis. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 15 Literaturangaben.
Abstract (Originalsprache)
Introduction
Inherited dysfibrinogenemia is a qualitative defect of fibrinogen caused by various mutations among three fibrinogen genes. Dysfibrinogenemia can be associated with an increased risk of thrombosis, bleeding, or both. Here, we report a 36-year-old female with dysfibrinogenemia who experienced two successful pregnancies under thromboprophylaxis after cerebral venous sinus thrombosis (CVST). Patients and Methods In addition to plasmatic coagulation tests, fibrinogen genes FGA, FGB, and FGG were screened using direct genomic DNA sequencing. The structural-functional implications of the detected mutation were analyzed in silico.
Results
Inherited dysfibrinogenemia was diagnosed in an index patient after CVST in a risk situation. Anticoagulation with warfarin was stopped after 12 months when the first pregnancy was planned. Pregnancy and spontaneous delivery (2020) was uncomplicated. A second pregnancy was interrupted because of acute cytomegalovirus infection and the third pregnancy was successful in 2022. Pregnancies were accompanied by thromboprophylaxis with enoxaparin 40 mg once daily until 6 weeks postpartum. Substitution of fibrinogen has not become necessary in the index patient so far. Genetic analysis revealed a novel missense mutation (p. Arg510Cys) in the FGA gene (“fibrinogen Bonn”) in the index patient, as well as an asymptomatic sister, and their father who experienced recurrent pulmonary embolism. Surface exposure of wild-type Arg510 suggested the mutated Cys510 to form nonnative disulfide bonds with surface-exposed reactive cysteines from other plasma proteins like albumin leading to formation of aggregates and impaired fibrinolysis.
Conclusions
Fibrinogen Bonn might be associated with an increased risk of thrombosis, possibly due to impaired polymerization.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Institute for Experimental Hematology and Transfusion Medicine, University Hospital Bonn, Bonn, Germany.
- Lithuanian University of Health Sciences, Kaunas, Lithuania.
Zitieren
APA
Ivaškevičius, V., Biswas, A., Singh, S., Stulpinaitė, U., Reda, S., Rühl, H., Pezeshkpoor, B., Pavlova, A., & Oldenburg, J. (2023). Fibrinogen Bonn (p. Arg510Cys) in the Aα-Chain Is Associated with High Risk of Venous Thrombosis. Hämostaseologie, 43(06), 440-446. https://doi.org/10.1055/a-2094-7191
Vancouver
Ivaškevičius V, Biswas A, Singh S, Stulpinaitė U, Reda S, Rühl H, et al. Fibrinogen Bonn (p. Arg510Cys) in the Aα-Chain Is Associated with High Risk of Venous Thrombosis. Hämostaseologie. 2023;43(06):440-446. doi:10.1055/a-2094-7191
BibTeX
@article{Ivakeviius2023,
author = {Ivaškevičius, V and Biswas, A and Singh, S and Stulpinaitė, U and Reda, S and Rühl, H and Pezeshkpoor, B and Pavlova, A and Oldenburg, J},
title = {Fibrinogen Bonn (p. Arg510Cys) in the Aα-Chain Is Associated with High Risk of Venous Thrombosis},
journal = {Hämostaseologie},
year = {2023},
volume = {43},
number = {06},
pages = {440--446},
doi = {10.1055/a-2094-7191}
}
EUVIMED